Research To Practice | Oncology Videos

Latest Episodes:

Melanoma and Nonmelanoma Skin Cancers | Evan J Lipson, MD Aug 17, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers | Faculty Presentation 2: Localized Melanoma and Other Types of Skin Cancer — Evan J Lipson, MD

CME information and select publications

Melanoma and Nonmelanoma Skin Cancers | Omid Hamid, MD Aug 17, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers | Faculty Presentation 1: Metastatic Melanoma — Omid Hamid, MD

CME information and select publications

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture) Aug 16, 2023

Show notes

Featuring a slide presentation and related discussion from Dr Philip A Philip, including the following topics:

Comprehensive biomarker analysis for patients diagnosed with colorectal cancer (CRC) (0:00)
Selection and sequencing of systemic therapy for patients with metastatic CRC (11:48)
Prevalence of claudin-18.2 in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer (22:31)
Emerging systemic therapies for hepatocellular carcinoma (24:49)
Management of advanced biliary tract cancers (30:04)
Activity of NALIRIFOX (liposomal irinotecan/oxaliplatin/leucovorin/fluorouracil) for treatment-naïve metastatic pancreatic cancer (35:35)

CME information and select publications

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Aug 16, 2023

Show notes

Featuring an interview with Dr Philip A Philip, including the following topics:

Comprehensive biomarker analysis for patients diagnosed with colorectal cancer (CRC) (0:00)
Selection of first-line therapy for patients with metastatic CRC (mCRC) (7:51)
Therapeutic options for patients with HER2-positive mCRC (10:10)
Patient selection for regorafenib and/or TAS-102 with or without bevacizumab for mCRC (16:57)
Selection and sequencing of therapeutic options for patients with unresectable or metastatic gastric or gastroesophageal junction cancer (19:52)
Current and emerging immune checkpoint inhibitor-based combinations for hepatocellular carcinoma (24:51)
First- and later-line therapy for patients with advanced biliary tract cancers (33:17)
Activity of NALIRIFOX (liposomal irinotecan/oxaliplatin/leucovorin/fluorouracil) for treatment-naïve metastatic pancreatic cancer (36:12)

CME information and select publications

Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer Aug 14, 2023

Show notes

Featuring perspectives from Dr Neeraj Agarwal, Dr Emmanuel S Antonarakis, Prof Karim Fizazi and Dr Susan F Slovin, including the following topics:

Introduction: Current landscape of prostate cancer treatment (0:00)
Relevance of homologous recombination repair mutations in castration-resistant prostate cancer: Treatment with PARP inhibitors as monotherapy — Dr Antonarakis (12:33)
Phase III PROpel and MAGNITUDE trials — Dr Slovin (35:44)
PARP inhibitor combination treatments for advanced prostate cancer — Dr Agarwal (57:08)
Future directions in the use of PARP inhibitors for prostate cancer — Prof Fizazi (1:23:49)
Journal Club (1:35:53)
Case discussions (2:11:57)

CME information and select publications

Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture) Aug 11, 2023

Show notes

Featuring a slide presentation and related discussion from Dr Floor J Backes, including the following topics:

Recent updates from ASCO 2023 in the management of ovarian cancer (0:00)
Recent updates from ASCO 2023 in the management of endometrial cancer (36:08)
Recent updates from ASCO 2023 in the management of cervical cancer (41:48)

CME information and select publications

Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Aug 11, 2023

Show notes

Featuring perspectives from Dr Floor J Backes, including the following topics:

Available data with and clinical investigator perspectives on trastuzumab deruxtecan for the management of gynecologic cancers (0:00)
Patient-specific factors guiding treatment selection and sequencing for ovarian cancer (OC) (6:05)
Management of adverse events associated with PARP inhibitor maintenance therapy for OC; safety concerns in the later-line setting (15:00)
Management approaches for ocular toxicity and other adverse events associated with mirvetuximab soravtansine (20:28)
Current role of upifitamab rilsodotin in the management of OC and available data with tumor treating fields (24:38)
Investigator perspectives on the current chemotherapy shortage; recently published Phase III data with chemoimmunotherapy for endometrial cancer (29:11)
Tisotumab vedotin for cervical cancer (36:34)

CME information and select publications

Urothelial Bladder Cancer | Petros Grivas, MD, PhD Aug 10, 2023

Show notes

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer | Faculty Presentation 2: Available Data with, Ongoing Investigation of and Role of Other Novel Strategies for mUBC — Petros Grivas, MD, PhD

CME information and select publications

Urothelial Bladder Cancer | Terence Friedlander, MD Aug 10, 2023

Show notes

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer | Faculty Presentation 1: Immunotherapy-Based Strategies for Metastatic Urothelial Bladder Cancer (mUBC) — Terence Friedlander, MD

CME information and select publications

Urothelial Bladder Cancer | Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer Aug 10, 2023

Show notes

Featuring perspectives from Dr Terence Friedlander and Prof Petros Grivas, including the following topics: